Cognitive impairment in patients with diabetes mellitus type 2 and possibilities of its treatment

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 2014, Issue 9, 2014, Pages 25-29

  Kh Khayrullin, I ^a   Esin, R G ^a   Pozdnyak, A O ^a  

^a KAZAN STATE MEDICAL ACADEMY   (Russian Federation)

Author keywords

Cognitive function; Cognitive impairment; Diabetes 2 type; EGb 761

Indexed keywords

GINKGO BILOBA EXTRACT; GINKGO BILOBA EXTRACT 761; PLANT EXTRACT;

ARTICLE; ATTENTION DISTURBANCE; COGNITION; COGNITIVE DEFECT; DRUG EFFICACY; GINKGO BILOBA; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGIC TEST; SHORT TERM MEMORY; THINKING; COGNITION DISORDERS; COMPLICATION; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PHYTOTHERAPY; PSYCHOLOGY;

COGNITION; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84927800830     PISSN: 19977298     EISSN: 23094729     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Elias P., Elias M., D'Agostino R., Cupples L., Wilson P., Silbershatz H., Wolf P. A. NIDDM and blood pressure as risk factors for poor cognitive performance. Diabet Care 1997; 20: 1388-1395.
2. Miles W., Root H. Psychologic tests applies in diabetic patients. Archives of International Medicine 1922; 30: 767-770.
3. Gregg E., Yaffe K., Cauley J., Rolka D., Blackwell T., Narayan K., Cummings S. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arc of Int Med 2000; 160: 174-180.
4. Ott A., Stolk R., Hofman A., van Harskamp F., Grobbee D., Breteler M. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996; 39: 1392-1397.
5. Li Z-G., Zhang W., Sima A. A. F. C-peptide enhances insulin-mediated cell growth and protection against high glucose induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev 2003; 19: 375-385.
6. Hayden M., Shosh S. Signaling to NF-kappa B. Genes and Development 2004; 18: 2195-2224.
7. Brunton S. Beyond glycemic control: treating the entire type 2 diabetes disorder. Postgrad Med 2009; 121: 5: 68-81.
8. Taliyan R., Sharma P. Protective effect and potential mechanism of EGb 761 on STZ-induced neuropathic pain in rats. Phytother Res 2012; 26: 12: 1823-1829.
9. Lim S., Yoon J. W., Kang S. M., Choi S. H., Cho B. J., Kim M., Park H. S., Cho H. J., Shin H., Kim Y. B., Kim H. S., Jang H. C., Park K. S. EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 2011; 6: 6: 20301.
10. da Silva G., Zanoni J., Buttow N. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J of Gastroent 2011; 17: 7: 898-905.
11. Mozet C., Martin R., Welt K., Fitzl G. Cardioprotective effect of EGb 761 on myocardial ultrastructure of young and old rat heart and antioxidant status during acute hypoxia. Aging Clinical and Experimental Research 2009; 21: 1: 14-21.
12. Schneider R., Welt K., Aust W., Kluge R., Loster H., Fitzl G. Cardiovascular autonomic neuropathy in spontaneously diabetic rats with and without application of EGb 761. Histol and Histopathol 2010; 25: 12: 1581-1590.
13. Welt K., Weiss J., Martin R., Hermsdorf T., Drews S., Fitzl G. Ginkgo biloba extract protects rat kidney from diabetic and hypoxic damage. Phytomedicine 2007; 14: 196-203.
14. Kudolo G. B., Wang W., Elrod R., Barrientos J., Haase A., Blodgett J. Shortterm ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects-a randomized double-blind placebo-controlled crossover study. Clinical Nutriology 2006; 25: 1: 123-134.